Abstract
Autoimmune disorders are increasingly recognized causes of several neurological disorders leading to significant clinical disability. This article reviews recent developments in our understanding on the pathophysiology, clinical presentations, and diagnoses of selected immune-mediated neurological disorders. It also provides a brief summary of current theories on autoimmunity and the role that certain environmental factors play in the development of immune-mediated neurological disorders. Recently recognized biomarkers might play a pathogenetic role or simply serve as a diagnostic tool.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: Of importance
Fang F, Sveinsson O, Thormar G, Granqvist M, Askling J, Lundberg IE, et al. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. J Intern Med. 2014.
Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–43. PubMed The importance of this article is based on the analysis on epidemiological factors and population based studies that might explain pathophysiology of autoimmune disorders with particular emphasis on MS.
Van Loveren HVJ, Germolec D, Simeonova PP, Eijkemanns G, McMichael AJ. Epidemiologic associates between occupational and environmental exposures and autoimmune disease: report of a meeting to explore current evidence and identify research needs. Int J Hyg Environ Health. 2001;203:483–95.
D'Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14(5):363–9. PubMed.
Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus. 2014;23(6):518–26. PubMed Pubmed Central PMCID: 4009622.
Farez MF, Fiol MP, Gaitan MI, Quintana FJ, Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(1):26–31. PubMed.
Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1)
Correale J, Equiza TR. Regulatory B cells, helminths, and multiple sclerosis. Methods Mol Biol. 2014;1190:257–69. PubMed This article reviews the potential role of helminths and other infections in autoimmune disorders. Is a key article to understand the role of hygiene hypothesis in MS.
Billingham REBL, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–6.
Burnet SFM. The clonal selection theory of acquired immunity: University Press Cambridge; 1959.
Janeway CA. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989;54:1–13.
Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994.
Bolon B. Cellular and molecular mechanisms of autoimmune disease. Toxicol Pathol. 2012;40(2):216–29.
Schwartz R. T cell anergy. Annu Rev Immunol. 2003;21:305–34.
Mondino AKA, Jenkins MK. The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A. 1996;93:2245–52.
Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222–5.
Muppidi S, Vernino S. Paraneoplastic neuropathies. Continuum. 2014 (5 Peripheral Nervous System Disorders):1359–72.
Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones Jr LK. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012;46(5):823–7.
Struck AF, Salamat S, Waclawik AJ. Motor neuron disease with selective degeneration of anterior horn cells associated with non-Hodgkin lymphoma. J Clin Neuromuscul Dis. 2014;16(2):83–9.
Sheikh SI, Amato AA. The dorsal root ganglion under attack: the acquired sensory ganglionopathies. Pract Neurol. 2010;10(6):326–34.
Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grunewald RA, Davies-Jones AG. Sensory ganglionopathy due to gluten sensitivity. Neurology. 2010;75(11):1003–8.
Gorson KC, Herrmann DN, Thiagarajan R, Brannagan TH, Chin RL, Kinsella LJ, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79(2):163–9.
Sinnreich M, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology. 2004;63(9):1662–9.
Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13(1):67–82.
Dyck PJ, Thaisetthawatkul P. Lumbosacral plexopathy. Continuum. 2014 (5 Peripheral Nervous System Disorders):1343–58
Oger J, Frykman H. An update on laboratory diagnosis in myasthenia gravis. Clin Chim Acta. 2015;444:126–31.
Liewluck T, Selcen D, Engel AG. Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia. Muscle Nerve. 2011;44(5):789–94.
Greenberg SA. Cytoplasmic 5′-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility. Muscle Nerve. 2014;50(4):488–92.
Ellwardt EZF. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS. J Exp Neurol. 2014;262(Part A):8–17. Great review on the interplay between inflammation and neurodegeneration in MS.
Gul M, Chaudhry AA, Chaudhry AA, Sheikh MA, Carsons S. Atypical presentation of CLIPPERS syndrome: a new entity in the differential diagnosis of central nervous system rheumatologic diseases. J Clin Rheumatol : Pract Rep Rheum Musculoskelet Dis. 2015;21(3):144–8.
Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol. 1999;9(2):275–84.
Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, Wojnoonski K, et al. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science. 2008;319(5860):215–20.
Compliance with Ethics Guidelines
Conflict of Interest
Teerin Liewluck and Augusto Miravalle declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Neurology of Systemic Diseases
Rights and permissions
About this article
Cite this article
Liewluck, T., Miravalle, A. Immune-Mediated Neurological Disorders. Curr Neurol Neurosci Rep 15, 61 (2015). https://doi.org/10.1007/s11910-015-0581-x
Published:
DOI: https://doi.org/10.1007/s11910-015-0581-x